Personalizing Breast Cancer Screening
Cancer detection in high-risk patients
Trends in breast MRI
Making personalized screening a routine
Share this page
Martin Lindneris is an award-winning science writer based in Berlin, Germany. After completing his medical studies and a doctoral thesis in the history of medicine, he went into journalism. His articles have appeared in many major German and Swiss newspapers and magazines.
All online sources last accessed Sept. 3rd, 2018
Riedl CC, Luft N, Bernhart C, et al. (2015) Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol 33:1128-35
Völzke H (2012) Study of Health in Pomerania (SHIP). Concept, design and selected results. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55:790-4
Bickelhaupt S, Jaeger PF, Laun FB, et al. (2018) Radiomics Based on Adapted Diffusion Kurtosis Imaging Helps to Clarify Most Mammographic Findings Suspicious for Cancer. Radiology. doi: 10.1148/ radiol.2017170273 [Epub ahead of print]
Adapting Breast Cancer Screening Strategy Using Personalised Risk Estimation (ASSURE), www.assure-project.eu/about-assure
My Personal Breast Screening (MyPeBS): A Randomized Comparison Of Risk Stratified versus Standard Breast Cancer Screening In European Women Aged 40-70, www.brumammo.be/documents/docs/bmmmy-pebs-clinical-trial-protocol.pdf
The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.
This article is not cleared for the United States.